89bio Inc (ETNB) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access ETNB Annual Balance Sheets →
The table below presents a historical view of 89bio Inc's balance sheet, supporting analysis of financial position trends.
Quarterly Report, GAAP in USD millions
ITEM
(Jun 30 2025)
(Mar 31 2025) (Dec 31 2024) (Sep 30 2024) (Jun 30 2024)
Assets
Cash & cash equivalent129.08
Marketable Securities, Current SH432.09
Cash & Short-term Investments561.00
Prepaid Expense And Other Assets Current40.36
Total Current Assets601.52
Equipment/Property/Plant Net0.08
Other Assets, Noncurrent1.89
Operating Lease Right Of Use Asset1.26
Total Assets603.49
Liabilities
Accounts Payable, Current AC14.66
Accrued Liabilities, Current AC24.17
Long-term Debt, Current Maturities LO0.00
Other Liabilities, Current0.78
Total Current Liabilities39.61
Long-term debt36.16
Total Long-term Debt36.16
Derivative Liability, Noncurrent DE0.00
Other liabilities, Noncurrent5.99
Operating Lease Liability Current0.78
Operating Lease Liability Noncurrent0.68
Total Liabilities81.75
Stockholders' Equity
Common Stock Value0.15
Additional Paid In Capital Common Stock1,528.75
Retained Earnings / Accumulated Deficit-1,007.29
Other Equity0.12
Common Stockholder's Equity521.73
Total Stockholder's Equity521.73
Liabilities & Stockholder's Equity603.49
4 historic quarters locked

Sign in to unlock the full 89bio Inc balance sheet history.

About 89bio Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-25-105939

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.